10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of August 9, 2026, TXG trades at $51.59 with a market cap of $6.61B and a P/E ratio of -303.44. TXG moved +14.36% today. Year to date, TXG is +219.01%; over the trailing twelve months it is +306.48%. Its 52-week range spans $6.78 to $52.22. Analyst consensus is buy with an average price target of $40.22. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10x Genomics, Inc. Class A Common Stock (TXG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TXG moved +14.36% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $51.59 |
| Market Cap | $6.61B |
| P/E Ratio | -303.44 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $52.22 |
| 52-Week Low | $6.78 |
| Volume | 4.75M |
| Avg Volume | 0 |
| Revenue (TTM) | $638.78M |
| Net Income | $-22.66M |
| Gross Margin | 69.60% |
11 analysts cover TXG: 0 strong buy, 3 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.22.